Fig. 1

TSQM-9 (a) and LQI (b) scores following manual administration of Ig20Gly in the CANCUN study. Values presented for patients who provided feedback; the number of patients with available data was not provided for each subcategory of the TSQM-9 or LQI scores. The TSQM-9 recall period was 2–3 weeks from the study visit date or since the last Ig20Gly administration. For TSQM-9 and LQI, scores for each domain were calculated by summing the items in each domain and then transforming into a value ranging from 0 to 100 (higher scores indicated better satisfaction/status). CANCUN CANadian CUvitru Non-interventional, Ig20Gly immune globulin subcutaneous (human) 20% solution, stabilized with glycine, LQI Life Quality Index, SD standard deviation, TSQM-9 9-item Treatment Satisfaction Questionnaire for Medication